Growth Metrics

Nu-Med Plus (NUMD) Net Cash Flow (QoQ) (2012 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nu-Med Plus - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 88.73%
Jun 30, 2024 -414.44%
Mar 31, 2024 89.49%
Dec 31, 2023 77.31%
Sep 30, 2023 18.22%
Jun 30, 2023 -14.41%
Mar 31, 2023 17.46%
Dec 31, 2022 -3,990.61%
Sep 30, 2022 124.75%
Jun 30, 2022 72.24%
Mar 31, 2022 54.68%
Dec 31, 2021 50.81%
Sep 30, 2021 38.30%
Jun 30, 2021 -34.92%
Mar 31, 2021 -131.36%
Dec 31, 2020 518.34%
Sep 30, 2020 307.76%
Jun 30, 2020 -208.65%
Mar 31, 2020 132.36%
Dec 31, 2019 -232.91%
Sep 30, 2019 444.56%
Jun 30, 2019 94.74%
Mar 31, 2019 -19,157.28%
Dec 31, 2018 99.38%
Sep 30, 2018 -1,025.69%
Jun 30, 2018 117.16%
Mar 31, 2018 -29.78%
Dec 31, 2017 -139.97%
Sep 30, 2017 369.91%
Jun 30, 2017 -117.70%
Mar 31, 2017 2,656.82%
Dec 31, 2016 130.36%
Sep 30, 2016 26.82%
Jun 30, 2016 -187.79%
Mar 31, 2016 84.86%
Dec 31, 2015 392.39%
Sep 30, 2015 -361.81%
Jun 30, 2015 94.75%
Mar 31, 2015 -14.48%
Dec 31, 2014 -169.11%
Sep 30, 2014 73.03%
Jun 30, 2014 677.13%
Mar 31, 2014 -108.39%
Dec 31, 2013 74,104.55%
Sep 30, 2013 -98.06%
Jun 30, 2013 51.93%
Mar 31, 2013 103.18%
Dec 31, 2012 -460.29%
Sep 30, 2012 60.07%
Jun 30, 2012 -172.31%